# Johan Richter

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/johan-richter/

## Facts

| Field | Value |
| --- | --- |
| Citations | 8,908 |
| Field | Chronic Myeloid Leukemia Treatments |
| h-index | 47 |
| i10-index | 125 |
| Last Known Institution | Lund University |
| OpenAlex ID | https://openalex.org/A5062726602 |
| ORCID iD | 0000-0002-0374-6823 |
| Works | 279 |

## Researcher papers

- [European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia](https://scholariq.org/papers/european-leukemianet-2020-recommendations-for-treating-chronic-myeloid-leukemia/)
- [Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial](https://scholariq.org/papers/discontinuation-of-tyrosine-kinase-inhibitor-therapy-in-chronic-myeloid/)
- [Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/chronic-myeloid-leukaemia-esmo-clinical-practice-guidelines-for-diagnosis/)
- [The concept of treatment-free remission in chronic myeloid leukemia](https://scholariq.org/papers/the-concept-of-treatment-free-remission-in-chronic-myeloid-leukemia/)
- [Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia](https://scholariq.org/papers/increased-proportion-of-mature-nk-cells-is-associated-with-successful-imatinib/)
- [Success Story of Targeted Therapy in Chronic Myeloid Leukemia: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2008](https://scholariq.org/papers/success-story-of-targeted-therapy-in-chronic-myeloid-leukemia-a-population-based/)
- [Murine models of acute neuronopathic Gaucher disease](https://scholariq.org/papers/murine-models-of-acute-neuronopathic-gaucher-disease/)
- [Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein](https://scholariq.org/papers/isolation-and-killing-of-candidate-chronic-myeloid-leukemia-stem-cells-by/)
- [Single-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CML](https://scholariq.org/papers/single-cell-molecular-analysis-defines-therapy-response-and-immunophenotype-of/)
- [Tumor necrosis factor-induced degranulation in adherent human neutrophils is dependent on CD11b/CD18-integrin-triggered oscillations of cytosolic free Ca2+.](https://scholariq.org/papers/tumor-necrosis-factor-induced-degranulation-in-adherent-human-neutrophils-is/)
- [Gene therapy for infantile malignant osteopetrosis: review of pre-clinical research and proof-of-concept for phenotypic reversal](https://scholariq.org/papers/gene-therapy-for-infantile-malignant-osteopetrosis-review-of-pre-clinical/)

## Researcher topics

- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Eosinophilic Disorders and Syndromes](https://scholariq.org/topics/eosinophilic-disorders-and-syndromes/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)

## Researcher university

- [Lund University](https://scholariq.org/institutions/lund-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.